Last edition
News about Global Pharma
Aarti Drugs to Use Solar Energy in Company's Operations to Promote Sustainability
Aarti Drugs has partnered with Prozeal Green Energy to procure solar power through a captive arrangement, acquiring a 26.25 percent stake in an SPV for INR 8.05 crore to develop a 24.40 MWp solar power plant.
Global Pharma | 04/02/2025 | By Manvi | 796
Cosette Pharma Appoints Brad Leonard as Vice President-Generics Commercial Operation
Brad played a pivotal role in the growth and success of Upsher-Smith Laboratories, LLC using a customer-focused approach to enhance their financial performance and commercial presence - demonstrated by over eight HDMA Diana Awards for product excellence and overall company performance.
Global Pharma | 04/02/2025 | By Aishwarya | 647
Vanda and Anaptys to Develop and Commercialize Imsidolimab
GPP is a rare skin disorder often caused by mutations in the IL36RN gene that codes for a regulatory protein that balances the activity of the proinflammatory IL-36 family of cytokines.
Global Pharma | 04/02/2025 | By Aishwarya | 585
Moberg Pharma AB and Allderma Announce Launch of Terclara in Norway
Moberg Pharma AB and Allderma have announced the launch of Terclara (MOB-015) in Norway, following its success in Sweden, with initial pharmacy deliveries expected in February 2025.
Global Pharma | 03/02/2025 | By Manvi | 567
Alterity Therapeutics has raised approximately AUD 2.13 million in the US via its at-the-market (ATM) facility and expects to receive around AUD 5.69 million in rebates from the Australian Taxation Office, enabling the acceleration of clinical and business development activities for its lead asset, ATH434.
Global Pharma | 03/02/2025 | By Manvi | 115
Clinigen Announces Collaboration with Tepsivo
At the heart of Tepsivo’s offering is its cutting-edge PV platform and proprietary automated PV software powered by artificial intelligence and other digital innovations.
Global Pharma | 03/02/2025 | By Aishwarya | 268
Cognizant Extends Alliance with Gilead to Boost Advanced Technology Applications
Gilead is expected to enhance its efficiency through leveraging Cognizant's expertise in AI and advanced technology applications.
Global Pharma | 03/02/2025 | By Aishwarya | 431
Union Budget 2025 to Ease Drug Costs with More Medicines Under Assistance Schemes
The Union Budget also expands the list of medicines that will be exempt from Basic Customs Duty under pharmaceutical companies’ Patient Assistance Programmes.
Global Pharma | 01/02/2025 | By Aishwarya | 1140
Kadimastem Shareholders Approve Merger with NLS Pharmaceutics
The merger brings NLS and Kadimastem one step closer to creating a combined Nasdaq-traded biotechnology company with a robust portfolio of advanced therapies for neurodegenerative diseases and diabetes.
Global Pharma | 01/02/2025 | By Abha | 299
OneSource Achieves INR 3,926 Million Revenue in Q3FY25
OneSource demonstrated exceptional profitability with EBITDA reaching INR 1,432 million, an 85 percent increase compared to the previous quarter, resulting in a robust EBITDA margin of 36.5 percent, up by 1,334 basis points quarter-on-quarter.
Global Pharma | 01/02/2025 | By Aishwarya | 848
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy